AI for Pharma and Biotech Market Poised for Explosive Growth Amid Advancements in Drug Discovery and Precision Medicine https://dataintelo.com/report/global-ai-for-pharma-and-biotech-market The AI for Pharma and Biotech Market is witnessing transformative growth driven by the rising integration of artificial intelligence in drug development, clinical trials, and personalized medicine. Valued at USD 2.1 billion in 2024, the market is projected to reach USD 9.8 billion by 2032, expanding at a robust CAGR of 21.4% over the forecast period. Artificial intelligence (AI) is revolutionizing how pharmaceutical and biotech industries conduct R&D by accelerating data analysis, improving diagnostic accuracy, and reducing the time and cost of drug development. AI’s capability to handle complex biological datasets is fueling its adoption across various stages of the value chain—from target identification to real-world evidence modeling.